Stock-based Compensation (Restated) (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of measurement of shares issued

Measurement Periods ending on or prior to December 31, 2024:

Number of Hospitals	End of Measurement Period	Number of Shares Issuable	Number of Shares Issued to Date	Inception-to-date Compensation Expense		Year-to-date 2024 Compensation Expense
1	February 28, 2023	—	—	$	—	$	—
2	February 29, 2024	27,035	27,035	458,249		(129,743)
3		27,035	27,035	$	458,249	$	(129,743)

Measurement Periods ending after December 31, 2024:

Number of Hospitals	End of Measurement Period	Estimated Number of Shares Issuable	Estimated Compensation Expense		Inception-to-date Compensation Expense		Year-to-date 2024 Compensation Expense
1	February 28, 2025	320,500	$	7,522,000	$	7,230,000	$	7,230,000
2	June 30, 2025	305,400	7,176,000		6,080,000		6,080,000
1	August 31, 2025	160,200	3,782,000		3,046,000		3,046,000
1	March 31, 2026	—	—		—		—
1	November 30, 2026	—	—		—		—
1	December 31, 2026	—	—		—		—
7		786,100	$	18,480,000	$	16,356,000	$	16,356,000

Schedule of stock-based awards activity

The following table summarizes stock-based awards activity:

	Options Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)
Options outstanding at December 31, 2022	34,318	$	348.16	7.60
Options exercised	—	—
Options cancelled	(6,728)	342.00
Options outstanding at December 31, 2023	27,590	335.78		6.94
Options exercised	—	—
Options cancelled	(5,625)	352.98
Options outstanding at December 31, 2024	21,965	$	331.34	5.45

Schedule of stock options outstanding

Options outstanding as of December 31, 2024 consisted of:

Expiration Date	Number Outstanding	Number Exercisable	Exercise Price
February 21, 2025	686	686	$	225.00
February 21, 2025	1,214	1,214	412.50
January 27, 2027	300	300	225.00
May 11, 2027	1,201	1,201	225.00
June 9, 2027	167	167	376.50
January 28, 2028	300	300	241.50
August 4, 2029	68	68	834.00
January 27, 2030	1,115	1,115	225.00
January 27, 2030	300	300	241.50
January 28, 2031	6,667	6,667	241.50
September 9, 2031	9,446	9,446	412.50
December 17, 2031	501	501	525.00
Total	21,965	21,965

Schedule of changes in restricted stock units

The following table summarizes the changes in restricted stock units during the years ended December 31, 2024 and 2023.

	Shares (in thousands)	Weighted Average Grant-Date Fair Value Per Share
Non-vested awards, December 31, 2022	—	$	—
Granted	4	151.50
Vested	(1)	151.50
Non-vested awards, December 31, 2023	3	151.50
Granted	118	5.40
Forfeitures	(3)	92.48
Vested	(1)	151.50
Non-vested awards, December 31, 2024	117	$	37.23